Pillstats
Rx only · Tablet, Extended Release · Oral

Metformin Er 500 Mg

Brands: Metformin · Metformin Hydrochloride

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)6809
US makers7 labelers
Packages33
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.009$0.017$0.026$0.034Dec 2025Apr 2026Jul 2026
$0.029
Latest avg · Jul 22, 2026
-2%
Since Dec 17, 2025
7
Active US suppliers
67%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

194K388K583K777K2025 Q12025 Q22025 Q32025 Q42026 Q1
441K
Rx · 2026 Q1
50.9M
Units dispensed
-35%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it7 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager16SUPPLYING
Granules Pharmaceuticals Incunknown6SUPPLYING
Proficient Rx LPunknown4SUPPLYING
REMEDYREPACK INC.repackager4SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING
Coupler LLCunknown1SUPPLYING
Legacy Pharmaceutical Packaging, LLCunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jul 3, 2020
    RECALLRecall (Class II): Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, a) 100 ct. bottle (NDC 70010-492-01) and 500 ct. bottle (…

    CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level — Recalling firm: Granules Pharmaceuticals Inc — US Nationwide